Patent 7850990 was granted and assigned to Celator Pharmaceuticals on December, 2010 by the United States Patent and Trademark Office.
Compositions which comprise delivery vehicles having stably associated therewith non-antagonistic combinations of two or more agents, such as antineoplastic agents, are useful in achieving non-antagonistic effects when combinations of drugs are administered.